Multifunctional biocontrol strain for combating banana fusarium wilt (TR4)

Overview

This offering centers on a single, well-characterized bacterial strain classified as GRAS (Generally Recognized as Safe) that demonstrates broad-spectrum fungicide activity against multiple phytopathogenic fungi, including strains of Fusarium oxysporum. Of particular relevance to the banana industry, the strain shows inhibitory effects against Fusarium oxysporum f. sp. cubense Tropical Race 4 (TR4), the causal agent of Panama disease that has devastated Cavendish banana plantations worldwide. The research explores multiple complementary biocontrol mechanisms, including the production of volatile organic compounds (VOCs), toxins, and diffusible molecules, as well as the use of secretion systems to directly target fungal pathogens. This multi-mechanism approach increases robustness and reduces the likelihood of pathogen resistance development.

Technical specifications

Key features:

• A GRAS-classified bacterial strain with demonstrated in vitro inhibition of several phytopathogenic fungi, including Fusarium oxysporum strains
• Multi-biocontrol capacity combining VOCs, diffusible metabolites, toxins, and secretion system machinery
• Genomic sequencing and biosynthetic pathway mining to identify biocontrol-related genes and metabolite clusters
• Extraction, purification, and characterization of active VOCs and diffusible molecules responsible for antifungal activity
• In planta validation using seed germination assays and nursery plantlet trials to monitor disease index reduction
• Flexible application formats including whole-cell biocontrol, isolated VOC compounds, or purified diffusible molecules
• Pathway toward engineered production systems for scalable deployment

Technology readiness level

The technology is currently at an early-to-mid stage of development. The bacterial strain has already been isolated and characterized for plant growth promotion and biocontrol activities, with confirmed in vitro fungicide activity. The research roadmap spans five objectives: genomic characterization and biosynthetic pathway mining, targeted in vitro testing against TR4, identification of active metabolites, in planta validation in seeds and nursery plantlets, and engineering of a production system. Objectives 1 through 4 are achievable within approximately one year, while the development of scalable production systems (Objective 5) will be pursued based on partner needs and may require additional time. The technology is not yet commercially deployed and is seeking collaborative partners to advance validation and production engineering.